Kura Oncology, Inc. Common Stock (NASDAQ: KURA) last traded at $11.89, up 1.54% on the session. The quote above updates while this page is open; the figures below are drawn from Kura Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kura Oncology, Inc. Common Stock trades on NASDAQ under the ticker KURA. Its market capitalisation is $1.06 billion.
Valuation measures for Kura Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.06B |
|---|---|
| Enterprise value | $1.53B |
| Price / sales | 13.70 |
| Price / book | 21.84 |
| Beta | 1.41 |
Trailing-twelve-month figures tagged in Kura Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $77.22M |
|---|---|
| Net income (TTM) | -$296.77M |
| EPS (TTM) | -$3.37 |
| Operating margin | -411.90% |
| Return on equity | -612.78% |
| Cash | $70.24M |
Range and volume for KURA over the past 52 weeks.
| 52-week high | $12.90 |
|---|---|
| 52-week low | $7.36 |
| Volume | 1.91M |
| Average volume | 1.77M |
| Previous close | $11.71 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.